Australien fügt Esketamin-Nasenspray für behandlungsresistente Depression hinzu
Beginning May 1, 2025, Australians suffering from treatment-resistant depression will have access to a new medication, esketamine, under the Pharmaceutical…
Schlagwort: esketamine
Esketamine with SNRI reduces treatment-resistant depression risks
Major depressive disorder (MDD) impacts about 280 million individuals worldwide, making it a leading cause of disability and diminished quality…
German 
English 
French 
Russian 
Spanish 
Belarusian 
Ukrainian